Emami

Emami

621.50
+2.25
(0.36%)
Market Cap
27,128.48 Cr
EPS
18.48
PE Ratio
33.06
Dividend Yield
1.61 %
52 Week High
860.00
52 Week Low
507.70
PB Ratio
10.04
Debt to Equity
0.04
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from24 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+79.17 %
+79.17 %
Hold
Hold+20.83 %
+20.83 %
Sell
Sell0.0 %
0.0 %

Company News

View All News
Caret
positive
Diwakar Finvest Private Limited and Suraj Finvest Private Limited released pledged shares of Emami Limited from three financial institutions. Diwakar Finvest released 500,000 shares (0.11% stake) from Bajaj Finance Limited and 296,000 shares (0.07% stake) from Aditya Birla Finance Ltd. Suraj Finvest released 200,000 shares (0.05% stake) from IndusInd Bank Limited. The releases occurred between August 12-14, 2025, as per agreements with the respective lenders. Post-release, Diwakar Finvest's encumbered shares reduced from 18.64 million to 17.85 million shares, while Suraj Finvest's encumbered holdings decreased from 5.75 million to 5.55 million shares. Diwakar Finvest holds 22.63% in Emami while Suraj Finvest holds 24.20%.
positive
Emami is targeting growth through premium product offerings, expanding rural market reach, and pursuing global expansion. The company is focusing on healthy living products, online brands, and new product innovations as key strategies to drive revenue growth, enhance profitability, and build long-term value for stakeholders.
positive
Emami Limited submitted a corporate presentation detailing its performance and business overview. The personal care and healthcare company reported revenue of ₹3,809 crore with a 7.5% five-year CAGR and EBITDA margin of 26.9%. The company operates across multiple segments including Navratna Range (₹850 crore revenue), Pain Management Range (₹850+ crore), BoroPlus Range (₹600+ crore), Kesh King Range (₹300+ crore), and Male Grooming Range (₹200+ crore). Emami maintains market leadership positions in cool oils (67.5% volume share) and antiseptic creams (60.1% volume share). The company has presence across 145+ countries and reaches 5.4 million retail outlets in India. International business contributes 17% of revenue while acquired brands account for 28% of revenue. The debt-free company achieved ROE and ROCE of 33.4% and 32.6% respectively on adjusted PAT of ₹899 crore.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,252.80
#1 1,28,162.44
67.28
#1 14,680.40
2.19
#1 1,852
0.40
56.80
516.95
91,690.91
51.49
13,113.20
1.76
1,740
2.81
50.84
2,343.00
63,726.23
45.87
6,179.00
7.33
1,437
-11.92
60.02
13,484.00
43,770.06
52.51
3,411.80
7.57
637
#1 136.87
52.85
10,449.00
34,048.29
60.18
2,262.80
-14.91
418
25.60
47.02
620.90
#6 27,102.29
#2 33.06
#4 3,877.30
#6 6.96
#4 803
#5 9.10
61.47
298.25
9,698.60
132.18
2,066.95
#1 29.98
62
2.48
64.78
171.10
4,591.55
96.78
183.52
8.65
41
80.72
73.72
228.40
3,130.29
#1 25.97
1,000.40
-2.76
125
2.16
54.13
181.10
271.80
100.06
48.25
25.86
3
20.00
51.35
Forecast
Actual
Growth Rate
Revenue Growth
6.96 %
Net Income Growth
10.85 %
Cash Flow Change
15.00 %
ROE
1.15 %
ROCE
3.21 %
EBITDA Margin (Avg.)
2.58 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
576
555
542
729
613
651
582
722
579
535
633
762
619
619
633
820
657
660
676
828
547
488
743
943
777
672
825
988
801
780
856
990
850
834
876
1,013
902
917
912
1,064
984
926
Expenses
413
439
378
476
417
498
398
455
392
449
427
492
445
494
441
558
486
515
468
554
444
360
479
594
569
493
514
633
618
604
621
689
637
636
632
688
682
692
645
715
744
692
EBITDA
162
117
163
254
195
152
184
267
187
87
207
270
174
125
192
262
171
145
208
275
103
129
264
349
208
179
311
355
183
175
235
301
213
198
244
325
220
225
267
349
240
234
Operating Profit %
25 %
18 %
29 %
34 %
31 %
23 %
31 %
36 %
31 %
15 %
32 %
35 %
28 %
20 %
30 %
31 %
24 %
21 %
29 %
32 %
17 %
25 %
35 %
36 %
22 %
25 %
35 %
35 %
20 %
22 %
24 %
30 %
24 %
23 %
27 %
31 %
24 %
24 %
28 %
32 %
23 %
23 %
Depreciation
11
23
71
72
90
72
79
82
76
75
75
80
81
84
82
79
81
84
82
86
85
75
115
94
83
83
84
84
84
88
48
47
64
46
46
46
48
44
45
46
44
45
Interest
1
4
19
17
13
13
16
13
17
8
10
9
7
5
4
6
6
4
9
5
2
5
3
1
5
1
1
2
2
3
2
2
1
2
2
3
3
2
2
2
3
2
Profit Before Tax
152
91
74
166
92
68
89
172
94
4
121
181
87
37
106
176
84
57
117
184
15
49
147
253
120
95
226
269
98
85
186
252
148
150
196
276
169
178
220
301
194
187
Tax
14
4
14
32
10
12
23
38
11
3
23
34
27
10
24
39
28
18
21
40
-7
10
28
44
33
18
41
49
-256
12
5
19
6
13
16
16
23
28
9
22
32
23
Net Profit
138
86
60
134
83
57
66
134
83
1
99
147
60
27
82
138
56
39
96
144
23
40
118
209
88
78
185
220
354
73
180
233
142
137
180
261
147
151
211
279
162
164
EPS in ₹
6.09
3.82
2.67
5.92
3.62
2.50
2.91
5.92
3.67
0.05
4.35
6.49
2.63
0.59
1.82
3.03
1.24
0.86
2.12
3.18
0.51
0.88
2.66
4.70
1.97
1.75
4.17
4.94
8.03
1.67
4.17
5.37
3.27
3.13
4.09
5.92
3.41
3.50
4.87
6.39
3.72
3.76

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
1,676
2,692
2,603
2,801
2,822
2,679
2,520
3,058
3,110
3,280
3,534
Fixed Assets
453
1,974
1,994
1,802
1,680
1,459
1,132
1,344
1,245
1,114
984
Current Assets
1,144
505
441
701
849
1,033
1,127
1,073
1,287
1,418
1,734
Capital Work in Progress
29
67
22
31
36
8
6
3
6
8
15
Investments
495
47
128
314
187
156
255
303
293
442
676
Other Assets
700
604
460
655
919
1,055
1,126
1,408
1,565
1,717
1,859
Total Liabilities
1,676
2,692
2,603
2,801
2,822
2,679
2,520
3,058
3,110
3,280
3,534
Current Liabilities
387
735
782
714
680
792
700
916
724
759
779
Non Current Liabilities
55
342
65
73
67
64
58
68
73
63
61
Total Equity
1,235
1,616
1,756
2,014
2,076
1,823
1,762
2,074
2,313
2,458
2,693
Reserve & Surplus
1,208
1,589
1,732
1,991
2,031
1,778
1,718
2,033
2,259
2,403
2,651
Share Capital
23
23
23
23
45
45
45
44
44
44
44

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
82
-249
-72
-12
100
-106
9
8
19
6
52
Investing Activities
-237
-1,313
-306
-276
-26
-231
-224
-234
-122
-210
-345
Operating Activities
534
562
730
588
554
531
922
644
749
779
896
Financing Activities
-215
502
-496
-324
-428
-405
-688
-402
-608
-563
-500

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
53.86 %
53.86 %
53.86 %
53.86 %
54.27 %
54.27 %
54.27 %
54.27 %
54.27 %
54.52 %
54.84 %
54.84 %
54.84 %
54.84 %
54.84 %
54.84 %
54.84 %
54.84 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
13.46 %
14.02 %
14.38 %
14.11 %
12.11 %
11.89 %
DIIs
23.09 %
22.23 %
23.65 %
25.42 %
24.28 %
26.45 %
26.99 %
27.02 %
26.92 %
26.20 %
25.22 %
23.77 %
22.07 %
21.61 %
21.51 %
21.70 %
23.67 %
24.06 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
4.60 %
4.34 %
4.18 %
4.03 %
4.00 %
3.93 %
3.75 %
3.86 %
4.05 %
3.60 %
3.90 %
4.01 %
4.74 %
4.84 %
4.93 %
5.40 %
5.38 %
5.30 %
Others
18.46 %
19.57 %
18.32 %
16.70 %
17.45 %
15.35 %
14.99 %
14.85 %
14.76 %
15.68 %
16.05 %
17.38 %
4.89 %
4.69 %
4.34 %
3.95 %
4.00 %
3.89 %
No of Share Holders
0
82,090
81,508
82,193
83,257
86,242
89,971
85,460
90,285
89,955
79,216
82,151
91,334
97,258
1,27,897
1,28,725
1,29,002
1,26,599

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 7 7 4 4 8 8 8 8 10
Dividend Yield (%) 0.00 1.31 1.75 2.35 0.82 1.79 2.22 1.86 1.38 1.61

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
29 Aug 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
29 Aug 2025 629.95 619.55
22 Jun 2018 BONUS Bonus
1:1
21 Jun 2018 535.08 530.00
05 Feb 2021 DIVIDEND Dividend
₹ 4.00 /share
04 Feb 2021 484.95 502.20
09 Nov 2021 DIVIDEND Dividend
₹ 4.00 /share
08 Nov 2021 529.20 557.05
11 Feb 2022 DIVIDEND Dividend
₹ 4.00 /share
10 Feb 2022 508.55 501.60
21 Nov 2022 DIVIDEND Dividend
₹ 4.00 /share
18 Nov 2022 465.15 428.05
13 Feb 2023 DIVIDEND Dividend
₹ 4.00 /share
13 Feb 2023 422.15 409.70
15 Nov 2023 DIVIDEND Dividend
₹ 4.00 /share
15 Nov 2023 508.80 509.95
19 Feb 2024 DIVIDEND Dividend
₹ 4.00 /share
16 Feb 2024 485.65 460.00
27 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
27 Aug 2024 824.10 818.15
07 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Nov 2024 740.25 684.85
18 Nov 2024 DIVIDEND Dividend
₹ 4.00 /share
18 Nov 2024 684.85 640.45
27 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
27 Jan 2025 588.55 551.50
04 Feb 2025 DIVIDEND Dividend
₹ 4.00 /share
04 Feb 2025 551.50 614.30
16 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
16 May 2025 581.10 629.95
22 May 2025 DIVIDEND Dividend
₹ 2.00 /share
22 May 2025 629.95 607.70
31 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
31 Jul 2025 571.60 565.30

Announcements

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.2 days ago
Announcement Under Regulation 30 (LODR) - Corporate Presentation3 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation10 days ago
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 07, 2025
Business Responsibility and Sustainability Reporting (BRSR)Aug 05, 2025
Reg. 34 (1) Annual Report.Aug 04, 2025
Notice Of 42Nd AGM Of Emami Limited To Be Held On 29Th August 2025.Aug 04, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 04, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 04, 2025
Intimation For Authorization Of KMPAug 04, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 01, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJul 31, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationJul 31, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 31, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJul 31, 2025
Appointment of Company Secretary and Compliance OfficerJul 31, 2025
Financial Results For Quarter Ended 30Th June 2025Jul 31, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Dated 31St July 2025Jul 31, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 30, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 30, 2025
Change In Corporate Logo And Name Style Of CompanyJul 30, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 28, 2025
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Jul 18, 2025
Announcement under Regulation 30 (LODR)-AcquisitionJul 17, 2025
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Jul 09, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 08, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceJul 03, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 03, 2025
Board Meeting Intimation for Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The First Quarter Ended 30Th June 2025Jul 01, 2025
Closure of Trading WindowJun 26, 2025
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Jun 25, 2025
Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Jun 24, 2025
Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011Jun 23, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jun 23, 2025
Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 2011Jun 13, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 09, 2025
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Jun 06, 2025
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Jun 03, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 23, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 19, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 19, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 17, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 17, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 16, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 16, 2025
Appointment Of The Secretarial Auditor And The Internal Auditor Of The CompanyMay 16, 2025
Corporate Action-Board approves DividendMay 16, 2025
Appointment of Company Secretary and Compliance OfficerMay 16, 2025
Announcement under Regulation 30 (LODR)-Dividend UpdatesMay 16, 2025
Board Meeting Outcome for Outcome Of Board MeetingMay 16, 2025

Technical Indicators

RSI(14)
Neutral
61.47
ATR(14)
Less Volatile
17.52
STOCH(9,6)
Neutral
56.24
STOCH RSI(14)
Neutral
78.77
MACD(12,26)
Bullish
3.27
ADX(14)
Weak Trend
21.38
UO(9)
Bearish
58.86
ROC(12)
Uptrend And Accelerating
1.27
WillR(14)
Neutral
-23.29

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Franklin India Multi Cap Fund Direct-Growth
0.00%
-1089529
-1.22%
-1.31%
Bandhan Flexi Cap Fund Direct-Growth
0.64%
697940
0.57%
0.64%
SBI Consumption Opportunities Fund Direct-Growth
0.96%
500454
0.96%
0.96%
Nippon India Small Cap Fund Direct- Growth
0.95%
427809
0.09%
0.03%
Sundaram Large and Mid Cap Fund Direct-Growth
0.84%
427000
0.41%
0.38%
Mahindra Manulife Mid Cap Fund Direct - Growth
0.00%
-375481
-0.54%
-0.58%
UTI ELSS Tax Saver Fund Direct-Growth
0.80%
367137
0.61%
0.80%
Bandhan Value Fund Direct-Growth
0.58%
256985
0.19%
0.29%
Sundaram Flexi Cap Fund Direct - Growth
0.65%
225000
0.65%
0.65%
Bank of India Multi Cap Fund Direct-Growth
0.00%
-154921
-0.98%
-1.06%
Sundaram ELSS Tax Saver Fund Direct
0.65%
148000
0.65%
0.65%
Aditya Birla Sun Life Small Cap Fund Direct-Growth
0.66%
-125693
-0.09%
-0.14%
Sundaram Mid Cap Fund Direct-Growth
0.76%
117679
0.10%
0.37%
Bandhan Small Cap Fund Direct-Growth
0.19%
100000
0.04%
0.02%
DSP Dynamic Asset Allocation Fund Direct-Growth
0.55%
-89412
-0.13%
-0.15%
UTI Value Fund Direct-Growth
0.99%
68604
0.11%
0.05%
Bank of India Manufacturing & Infrastructure Fund Direct-Growth
0.00%
-56588
-0.53%
-0.58%
Bajaj Finserv Large and Mid Cap Fund Direct-Growth
0.67%
30860
0.13%
-0.05%
Bandhan Multi Asset Allocation Fund Direct-Growth
0.55%
20000
0.07%
0.08%
LIC MF Multi Cap Fund Direct - Growth
0.92%
12903
0.07%
0.01%
UTI Dividend Yield Fund Direct-Growth
1.04%
-10956
0.06%
0.01%
DSP Nifty Midcap 150 Quality 50 Index Fund Direct - Growth
1.70%
4913
0.14%
0.05%
Motilal Oswal Nifty Midcap 150 Index Fund Direct - Growth
0.33%
4717
0.03%
0.00%
Nippon India Nifty Midcap 150 Index Fund Direct - Growth
0.33%
3275
0.02%
0.00%
UTI Conservative Hybrid Fund Direct-Growth
0.24%
2000
0.02%
0.01%

About Emami

Emami Limited is a leading Indian FMCG company that manufactures and markets personal care and healthcare products. The company offers over 300 products across categories including hair care, skin creams, soaps, lotions, talcum powder, and ayurvedic healthcare products. Emami's portfolio includes well-known brands such as Navratna, BoroPlus, Fair & Handsome, Zandu Balm, and Kesh King. The company has a strong distribution network with products available in over 940,000 retail outlets across India and a global presence in more than 60 countries. Emami operates 8 manufacturing units in India and 1 in Bangladesh, with facilities certified for cGMP and ISO 9001:2000 standards. The company has expanded through acquisitions and new product launches, entering markets such as male grooming, feminine hygiene, and home hygiene products. Emami has also invested in strategic partnerships and subsidiaries to strengthen its market position and product offerings.
Listing Date
24 Mar, 2005(20 Years, -2 days)
Chairperson NameR S Goenka